Biora Therapeutics(BIOR)
搜索文档
Biora Therapeutics(BIOR) - 2021 Q2 - Earnings Call Presentation
2021-08-13 09:20
SECOND QUARTER 2021 – FINANCIAL RESULTS August 2021 FORWARD-LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this presentation, including statements concerning our plans, objectives, goals, strategies, future events, future revenues or performance, fina ...
Biora Therapeutics(BIOR) - 2021 Q2 - Quarterly Report
2021-08-12 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share PROG The Nasdaq Global Market FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File ...
Biora Therapeutics(BIOR) - 2021 Q1 - Earnings Call Presentation
2021-05-14 12:31
| --- | --- | --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|--------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | First Quarter 2021 Financial Results | | | | | | | | | May 13, 2021 | | | 2 ©2021 Progenity, Inc. All rights reserved. 2 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial ...
Biora Therapeutics(BIOR) - 2021 Q1 - Earnings Call Transcript
2021-05-14 11:28
Progenity, Inc. (PROG) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Robert Uhl - Managing Director, Westwicke ICR Dr. Harry Stylli - Chairman and Chief Executive Officer Eric d’Esparbes - Chief Financial Officer Conference Call Participants Steven Mah - Piper Sandler Andrew Cooper - Raymond James Catherine Schulte - Baird Dan Leonard - Wells Fargo Operator Good afternoon everyone. Welcome to the Progenity’s First Quarter 2021 Earnings Call. At this time, all participants are ...
Biora Therapeutics(BIOR) - 2021 Q1 - Quarterly Report
2021-05-13 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share PROG The Nasdaq Global Market FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE A ...
Biora Therapeutics(BIOR) - 2020 Q4 - Earnings Call Presentation
2021-03-19 18:19
progenity® 1 ©2020 Progenity, Inc. All rights reserved. 1 Business Update and Fourth Quarter and FY 2020 Financial Results March 18, 2021 2 ©2020 Progenity, Inc. All rights reserved. 2 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this presen ...
Biora Therapeutics(BIOR) - 2020 Q4 - Earnings Call Transcript
2021-03-19 10:04
Progenity, Inc. (PROG) Q4 2020 Results Conference Call March 18, 2021 4:30 PM ET Company Participants Robert Uhl - Managing Director, Westwicke ICR Dr. Harry Stylli - Chairman and CEO Eric d’Esparbes - CFO Conference Call Participants Steven Mah - Piper Sandler Catherine Schulte - Baird Sung Ji Nam - BTIG Andrew Cooper - Raymond James Dan Leonard - Wells Fargo Operator Welcome to the Progenity’s Fourth Quarter 2020 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker pr ...
Biora Therapeutics(BIOR) - 2020 Q4 - Annual Report
2021-03-18 00:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-39334 PROGENITY, INC. (Exact name of Registrant as specified in its Charter) Delaware (State or other jurisdiction of incorporation o ...
Progenity (PROG) Investor Presentation - Slideshow
2021-02-20 08:02
1 © 2021 Progenity, Inc. All rights reserved. CORPORATE PRESENTATION February 2021 FORWARD-LOOKING STATEMENTS This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this presentation, including statements concerning our plans, objectives, goals, strategies, future events, futur ...
Progenity (PROG) Presents At 2021 ICR Conference - Slideshow
2021-01-16 08:52
| --- | --- | --- | --- | --- | --- | |-------|-------|-------|------------------------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | Corporate Presentation ICR Investor Conference | | | | | | | January 14, 2021 | | | 2 ©2021 Progenity, Inc. All rights reserved. 2 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws, which statements are subject to substantial risks and uncertainties ...